# Viatris Inc.: Lenders, Customers and Owners

> US · LEI 254900ZZTSW7NL773X71
>
> 24 links from the documents that the companies file and the register of legal entities, as of 2026-11-13. A commitment is the commitment at the date of the agreement.

Page: https://annalist.io/atlas/viatris/

Figures of the company: https://annalist.io/company/viatris/brief.md

## Measures of Its Relationships

- Lenders named: 15
- Proven commitments: none proven
- Largest lender: none stated
- Customers named: 3
- Largest customer: Cencora, Inc. (11% of revenue)
- Named customers together: 26% of revenue
- Suppliers that name it: 1
- Owners named: 0
- Holdings: 0

## Lenders (15)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Bank of America, N.A.](https://annalist.io/atlas/bank-of-america-n-a/brief.md) | Named as administrative agent | Stated | [1] |
| [BANK OF AMERICA, N.A., individually](https://annalist.io/atlas/bank-of-america-n-a-individually/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Citibank, N.A.](https://annalist.io/atlas/citibank-n-a/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Deutsche Bank AG New York Branch](https://annalist.io/atlas/deutsche-bank-ag-new-york-branch/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [DNB Capital LLC](https://annalist.io/atlas/dnb-capital-llc/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Goldman Sachs Bank USA](https://annalist.io/atlas/goldman-sachs-bank-usa/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [ING Bank N.V., Dublin Branch](https://annalist.io/atlas/ing-bank-n-v-dublin-branch/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [JPMorgan Chase Bank, N.A.](https://annalist.io/atlas/jpmorgan-chase-bank-n-a/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Mizuho Bank, Ltd.](https://annalist.io/atlas/mizuho-bank-ltd/brief.md) | Named as a lender under 2 agreements | Stated | [1] [2] [3] |
| [Morgan Stanley Bank, N.A.](https://annalist.io/atlas/morgan-stanley-bank-n-a/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [MUFG Bank, Ltd.](https://annalist.io/atlas/mufg-bank-ltd/brief.md) | Named as a lender under 2 agreements | Stated | [2] [3] |
| [PNC Bank, National Association](https://annalist.io/atlas/pnc-bank-national-association/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Standard Chartered Bank](https://annalist.io/atlas/standard-chartered-bank/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [Sumitomo Mitsui Banking Corporation](https://annalist.io/atlas/sumitomo-mitsui-banking-corporation/brief.md) | Named as a lender under 1 agreement | Stated | [2] |
| [The Bank of Nova Scotia](https://annalist.io/atlas/the-bank-of-nova-scotia/brief.md) | Named as a lender under 1 agreement | Stated | [2] |

## Customers (3)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Cencora, Inc.](https://annalist.io/atlas/cencora/brief.md) | 11% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [1] |
| [McKesson Corporation](https://annalist.io/atlas/mckesson/brief.md) | 10% of the revenue of the supplier, fiscal year ended 31 Dec 2023 | Stated | [1] |
| [Cardinal Health, Inc.](https://annalist.io/atlas/cardinal-health/brief.md) | 5% of the revenue of the supplier, fiscal year ended 31 Dec 2023 | Stated | [1] |

## Suppliers (1)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Theravance Biopharma](https://annalist.io/atlas/theravance-biopharma-inc/brief.md) | 100% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | [4] |

## Holdings (3)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| Mylan Luxembourg S.À R.L. | Consolidates the entity | Register | [5] |
| Mylan Pharmaceuticals Inc. | Consolidates the entity | Register | [6] |
| Utah Acquisition Sub Inc. | Consolidates the entity | Register | [7] |

## Partners (2)

| Entity | Figure | Evidence | Documents |
| --- | --- | --- | --- |
| [Mapi Pharma Ltd.](https://annalist.io/atlas/mapi-pharma-ltd/brief.md) | Named as a collaboration partner | Stated | [1] |
| [Theravance Biopharma](https://annalist.io/atlas/theravance-biopharma-inc/brief.md) | Named as a collaboration partner | Stated | [1] |

## Source Documents

- [1] Form 10-K for the fiscal year ended 31 December 2025, 26 Feb 2026 (https://www.sec.gov/Archives/edgar/data/1792044/000179204426000013/vtrs-20251231.htm)
- [2] Second Amended and Restated Revolving Credit Agreement of 27 September 2024, 27 Sep 2024 (https://www.sec.gov/Archives/edgar/data/1792044/000095015724001314/ex10-1.htm)
- [3] Term Loan Credit Agreement of 1 July 2021, 1 Jul 2021 (https://www.sec.gov/Archives/edgar/data/1792044/000119312521206477/d50384dex102.htm)
- [4] Form 10-K for the fiscal year ended 31 December 2025, 23 Mar 2026 (https://www.sec.gov/Archives/edgar/data/1583107/000110465926033077/0001104659-26-033077-index.htm)
- [5] Record of MYLAN LUXEMBOURG S.À R.L. in the register of legal entities, 12 November 2026, 12 Nov 2026 (https://search.gleif.org/#/record/222100BNA82OLGXHL585)
- [6] Record of Mylan Pharmaceuticals Inc. in the register of legal entities, 12 November 2026, 12 Nov 2026 (https://search.gleif.org/#/record/894500ZQWJQXJPI6B828)
- [7] Record of Utah Acquisition Sub Inc. in the register of legal entities, 12 November 2026, 12 Nov 2026 (https://search.gleif.org/#/record/254900JOFV74IJ7H9933)

## Full Data

- [Every link of this entity with its claims (JSON)](https://annalist.io/api/v1/atlas/viatris.json)
- [The map of every entity (JSON)](https://annalist.io/api/v1/atlas.json)
- [Every link in one table (CSV)](https://annalist.io/api/v1/panel/links.csv.gz)

---

Figures come from official filings and are provided as they are, without warranty of accuracy or completeness. They are not investment advice.